Loading clinical trials...
Loading clinical trials...
Three Cycles Versus Six Cycles of Adjuvant Chemotherapy for the Patients With High-risk Retinoblastoma After Enucleation: Prospective Randomized Control Study
Conditions
Interventions
3 cycles chemotherapy
6 cycles chemotherapy
Locations
1
China
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Start Date
August 1, 2013
Primary Completion Date
April 1, 2024
Completion Date
April 1, 2024
Last Updated
April 9, 2024
NCT06679634
NCT03050268
NCT03267459
NCT06424301
NCT06972602
NCT02870907
Lead Sponsor
Sun Yat-sen University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions